Recombinant human erythropoietin (rhEPO) as an adjuvant for autologous blood transfusion
- PMID: 9849439
- DOI: 10.1016/s0959-8049(98)00188-9
Recombinant human erythropoietin (rhEPO) as an adjuvant for autologous blood transfusion
Comment on
-
Increased autologous blood donation in rectal cancer by recombinant human erythropoietin (rhEPO).Eur J Cancer. 1998 Jun;34(7):992-8. doi: 10.1016/s0959-8049(98)00021-5. Eur J Cancer. 1998. PMID: 9849445 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
